Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis. Diesinger T, Buko V, Lautwein A, Dvorsky R, et al. PLoS One 2020;15:e0235990.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Diesinger T, Buko V, Lautwein A, Dvorsky R, et al. Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis. PLoS One 2020;15:e0235990.
PMID: 32701948